Quantcast
Get breaking news alerts via email

Click here to manage your alerts
Initial public offerings scheduled to debut next week
First Published Jul 25 2014 12:25 pm • Last Updated Jul 25 2014 12:25 pm

New York • The following is a list of initial public offerings planned for the week of July 28:

Angion Biomedica Corp. - Uniondale, N.Y., 2.7 million shares, priced $10 to $12, managed by Aegis Capital. Proposed Nasdaq Capital Market symbol ANGN. Business: Developing therapies for injured organs that trigger the body’s natural regeneration.

Join the Discussion
Post a Comment

Auris Medical Holding AG - Zug, Switzerland, 6.9 million common shares, priced $10 to $12, managed by Jefferies, and Leerink Partners. Proposed Nasdaq symbol EARS. Business: Biotech developing treatments for tinnitus and other inner ear disorders.

Avalanche Biotechnologies Inc. - Menlo Park, Calif., 5.4 million shares, priced $13 to $15, managed by Jefferies, Cowen, and Piper Jaffray. Proposed Nasdaq symbol AAVL. Business: Early-stage biotech developing a gene therapy for wet AMD.

Bio Blast Pharma Ltd. - Tel Aviv, Israel, 3.3 million ordinary shares, priced $11 to $13, managed by Oppenheimer, and Roth Capital. Proposed Nasdaq Capital Market symbol ORPN. Business: Biotech developing treatments for rare and ultra-rare genetic diseases.

Catalent Inc. - Somerset, N.J., 42.5 million shares, priced $19 to $22, managed by Morgan Stanley, J.P. Morgan, and BofA Merrill Lynch. Proposed NYSE symbol CTLT. Business: Global provider of oral, injectable and respiratory drug delivery technologies.

FCB Financial Holdings Inc. - Weston, Fla., 8.7 million shares, priced $24 to $27, managed by Deutsche Bank, J.P. Morgan, and BofA Merrill Lynch. Proposed NYSE symbol FCB. Business: Consolidation of 54 failed and acquired banks in Miami and coastal Florida.

HealthEquity Inc. - Draper, Utah, 9.1 million shares, priced $10 to $12, managed by J.P. Morgan, and Wells Fargo. Proposed Nasdaq symbol HQY. Business: Offers an integrated platform for managing health savings accounts.

Lantheus Holdings Inc. - North Billerica, Mass., 9.3 million shares, priced $12 to $15, managed by Citigroup, and Jefferies. Proposed Nasdaq symbol LNTH. Business: Sells medical imaging agents used in the diagnosis of cardiovascular diseases.

Loxo Oncology Inc. - Stamford, Conn., 4.4 million shares, priced $12 to $14, managed by Cowen & Co., and Stifel. Proposed Nasdaq symbol LOXO. Business: Biotech developing small molecule therapeutics to treat solid tumors.


story continues below
story continues below

Macrocure Ltd. - Petach Tikva, Israel, 5.4 million ordinary shares, priced $13 to $15, managed by Credit Suisse, and Jefferies. Proposed Nasdaq symbol MCUR. Business: Late-stage biotech developing white blood cell injections to treat hard-to-heal wounds.

Marinus Pharmaceuticals Inc. - New Haven, Conn., 4 million shares, priced $12 to $14, managed by Stifel, and JMP Securities. Proposed Nasdaq symbol MRNS. Business: Early-stage biotech developing an add-on therapy for epilepsy.

Mobileye N.V. - Jerusalem, Israel, 27.8 million ordinary shares, priced, $17 to $19, managed by Goldman Sachs, Morgan Stanley, and Deutsche Bank. Proposed NYSE symbol MBLY. Business: Provider of camera-based technology to avoid automobile collisions.

SIRVA Inc. - Oakbrook Terrace, Ill., 11.6 million shares, priced $15 to $17, managed by Morgan Stanley, Goldman Sachs, and J.P. Morgan. Proposed Nasdaq symbol SRVA. Business: Provides domestic and international relocation services for employees.

Synchrony Financial - Stamford, Conn., 125 million shares, priced $23 to $25, managed by Goldman Sachs, J.P. Morgan, and Citigroup. Proposed NYSE symbol SYF. Business: Spinoff of GE’s private label credit card and consumer finance business.

Tobira Therapeutics Inc. - San Francisco, 4.6 million shares, priced $12 to $14, managed by BMO Capital Markets, JMP Securities, and Oppenheimer. Proposed Nasdaq symbol TBRA. Business: Biotech developing an immunotherapy treatment for liver disease (NASH) and HIV.

Transocean Partners LLC - Aberdeen, U.K., 17.5 million common units, priced $19 to $21, managed by Morgan Stanley, Barclays, and Citigroup. Proposed NYSE symbol RIGP. Business: LLC formed by Transocean to own three deepwater rigs in the Gulf of Mexico.

Vascular Biogenics Ltd. - Or Yehuda, Israel, 5.4 million ordinary shares, priced $13 to $15, managed by Deutsche Bank, and Wells Fargo. Proposed Nasdaq sybol VBLX. Business: Biotech developing gene therapies for certain cancers and inflammatory diseases.

VTTI Energy Partners LP - London, U.K., 17.5 million common units, priced $19 to $21, managed by Citigroup and J.P. Morgan. Proposed NYSE symbol VTTI. Business: Owns, operates, develops and acquires refined petroleum product and crude oil terminaling and related energy infrastructure assets.

Next Page >


Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment


About Reader Comments


Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Videos
Jobs
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.